Grant: Discovery Grants Program - Individual
Université de Montréal
$17,000.00
Rethinking and Formulating Integrative Methodologies for a Better Understanding of Quantitative Drug-Related Issues
FY 2016-17
Summary
The research program proposed here addresses highly topical issues that became very important with the increasing role that mathematics play in the drug research area. It focuses on the development of advanced and novel mathematical approaches that account for the variability and nonlinearity emanating from the patient's drug intake, drug disposition in the body and its action on it, with the aim to update the most widely used (pharmaco) metrics, previously formulated in a deterministic and static way, and to improve the overall mechanistic understanding of this complex interlationship. This reformulation takes different aspects : 1) with the integration of available pharmacokinetic (PK) and pharmacodynamic (PD) metrics together, usually considered separately in the drug assessment, to obtain more information-loaded metrics, then 2) the addition of the variability of drug input into these new integrative PKPD metrics, 3) retrace the patient's drug history from limited drug information, by considering realistic clinical situations that cannot be easily tested in practice, 4) formulate, for the first time, analytically or in approximative closed forms, the kinetics of more complex pharmacokinetic models with absorption and/or elimination of mixed nature. All these mathematical aspects are crucial to make the drug process more efficient and effective, adding rigour and rationality to the emerging area of pharmacometrics. Mathematical sciences can benefit, in turn, from the emergence of new pharmacological problems that are challenging in their quantitative nature and lead to new mathematical topics, such as those described in the current proposal, beyond the traditional area of establishment of biomathematical models for the description of biological phenomena. Going through this path, it will be possible to enrich the current modeling vision and potentially open a new area in applied mathematics. In fact, these mainstream pharmacomentric problems lie within the scope of public interest and are of high socioeconomic impact. Solving these mathematical problems presents conceptual and technical opportunities and challenges that will value the role of mathematicians for generations to come.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2015-03955
Name nom
Nekka, Fahima
Department département
Pharmacie, Faculté de - Pharmacie, Faculté de
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
17000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
2960
Research subject group en
Applied mathematics
Research subject group fr
Mathématiques appliquées
Research subject en
Mathematical modelling
Research subject fr
Modélisation mathématique
Partie
2
Nb partie
5
Application title
Rethinking and Formulating Integrative Methodologies for a Better Understanding of Quantitative Drug-Related Issues
Keyword
NSERC
Application summary
The research program proposed here addresses highly topical issues that became very important with the increasing role that mathematics play in the drug research area. It focuses on the development of advanced and novel mathematical approaches that account for the variability and nonlinearity emanating from the patient's drug intake, drug disposition in the body and its action on it, with the aim to update the most widely used (pharmaco) metrics, previously formulated in a deterministic and static way, and to improve the overall mechanistic understanding of this complex interlationship. This reformulation takes different aspects : 1) with the integration of available pharmacokinetic (PK) and pharmacodynamic (PD) metrics together, usually considered separately in the drug assessment, to obtain more information-loaded metrics, then 2) the addition of the variability of drug input into these new integrative PKPD metrics, 3) retrace the patient's drug history from limited drug information, by considering realistic clinical situations that cannot be easily tested in practice, 4) formulate, for the first time, analytically or in approximative closed forms, the kinetics of more complex pharmacokinetic models with absorption and/or elimination of mixed nature. All these mathematical aspects are crucial to make the drug process more efficient and effective, adding rigour and rationality to the emerging area of pharmacometrics. Mathematical sciences can benefit, in turn, from the emergence of new pharmacological problems that are challenging in their quantitative nature and lead to new mathematical topics, such as those described in the current proposal, beyond the traditional area of establishment of biomathematical models for the description of biological phenomena. Going through this path, it will be possible to enrich the current modeling vision and potentially open a new area in applied mathematics. In fact, these mainstream pharmacomentric problems lie within the scope of public interest and are of high socioeconomic impact. Solving these mathematical problems presents conceptual and technical opportunities and challenges that will value the role of mathematicians for generations to come.